The efficacy of enoxolone in reducing erythema and pain after laser treatment: A randomized split-face pilot study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Sun Young | - |
dc.contributor.author | Koh, Young Gue | - |
dc.contributor.author | Roh, Yoon Jin | - |
dc.contributor.author | Park, Kui Young | - |
dc.date.accessioned | 2024-04-30T06:30:27Z | - |
dc.date.available | 2024-04-30T06:30:27Z | - |
dc.date.issued | 2024-04 | - |
dc.identifier.issn | 1473-2130 | - |
dc.identifier.issn | 1473-2165 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/73551 | - |
dc.description.abstract | BackgroundEnoxolone, derived from licorice, possesses potent anti-inflammatory, and antioxidant properties. However, its effectiveness in alleviating post-laser reactions has not been extensively studied.AimsThis randomized split-face pilot study aimed to evaluate the effects of enoxolone on skin following laser treatment.Patients/MethodsTen healthy subjects underwent non-ablative 1550 nm Er:Glass fractional laser treatment and then randomly applied a moisturizer without enoxolone on one side of the face and a dermo-cosmetic formular containing 2% enoxolone mixed with the same moisturizer on the other side. The erythema index (EI), clinician's erythema assessment (CEA), and pain scores were recorded at 30 min, 60 min, and 24 h posttreatment.ResultsThe group treated with enoxolone showed significantly lower EI and CEA compared to the control group at 24 h posttreatment. Additionally, pain scores were notably reduced in the enoxolone-treated group 30 min after treatment.ConclusionsThis study suggests that dermo-cosmetic formular containing 2% enoxolone is effective in reducing erythema and pain following laser treatment. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY | - |
dc.title | The efficacy of enoxolone in reducing erythema and pain after laser treatment: A randomized split-face pilot study | - |
dc.type | Article | - |
dc.identifier.doi | 10.1111/jocd.16329 | - |
dc.identifier.bibliographicCitation | JOURNAL OF COSMETIC DERMATOLOGY | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 001202846800001 | - |
dc.identifier.scopusid | 2-s2.0-85190950023 | - |
dc.citation.title | JOURNAL OF COSMETIC DERMATOLOGY | - |
dc.type.docType | Article; Early Access | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | enoxolone | - |
dc.subject.keywordAuthor | erythema | - |
dc.subject.keywordAuthor | laser therapy | - |
dc.subject.keywordPlus | 18-BETA-GLYCYRRHETINIC ACID | - |
dc.subject.keywordPlus | LICORICE | - |
dc.subject.keywordPlus | SKIN | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.